Active case

Women’s Health Lawsuits /

Depo Provera Lawsuit

Depo Provera Lawsuit

People are filing Depo Provera lawsuits to obtain compensation for harmful health effects they suffered after use of the contraceptive injection.

Connect with an attorney

Case Overview

People are filing Depo Provera lawsuits to obtain compensation for harm they suffered after extended use of the birth control medication. Recent research found a possible connection between the contraceptive injection and meningioma tumors that form near the brain and the spinal cord.

Working with Us

Wondering what happens when you submit a form or give us a call? We spend time gathering information from you, and your initial call is always free.

What's important?

  • Names
  • Dates
  • Timeline of events
  • Related documents
Connect with Us

or call: 1.800.768.4026

Important Depo Provera lawsuit updates

  • October 10, 2024: Pfizer Healthcare Ireland released a warning to the Health Products Regulatory Agency, an Irish agency. The warning discussed the “increased risk of developing meningioma with high doses of medroxyprogesterone acetate.“
  • October 2024: No MDL or class action lawsuit has yet been filed. However, several personal injury and product liability lawsuits have been filed by those alleging Depo Provera or Depo SubQ Provera caused their meningioma.
  • March 2024: The British Medical Journal (BMJ) published a report stating that prolonged use of Depo Provera could increase the risk of meningioma.

Key takeaways about Depo Provera meningioma lawsuit

  • Depo-Provera meningioma lawsuits are being filed by women who developed dangerous brain tumors potentially resulting from their use of the contraceptive.
  • Meningiomas are tumors that develop in the tissue covering the brain and spinal cord. A recent BMJ study found users of Depo-Provera to possibly be at increased risk of meningiomas.
  • Other lawsuits pertaining to the side effects of contraceptive shots have been filed against Depo-Provera manufacturer Pfizer. In 2021, a class action lawsuit about bone density loss was settled. Pfizer paid $1.9 million to settle these Canadian class action claims.

Why are people filing Depo-Provera lawsuits?

People are filing Depo Provera lawsuits after a March 2024 study linked the birth control shot to meningioma, a type of brain and spinal tumor. Depo-Provera is the brand name for medroxyprogesterone acetate (MPA), an injectable form of birth control given every three months to stop ovulation and prevent pregnancy. 

Depo-Provera may cause dangerous side effects. A recent study linked the medication to meningioma, a tumor forming in the meninges (membranes near the brain and spinal cord). Meningiomas can affect brain tissue, nerves and blood vessels, and may lead to severe disability. 

Lawsuits filed by people who took Depo-Provera and developed meningioma are still in their early stages. There’s not yet a consolidated multidistrict litigation or a class action. If you took this birth control shot and developed meningioma, you may be qualified to file a lawsuit.

Depo-Provera brain tumor lawsuit criteria

  • You used brand-name Depo-Provera, Depo-SubQ Provera or an authorized generic medroxyprogesterone acetate birth control shot
  • You used Depo-Provera as a primary form of birth control more than twice
  • You used Depo-Provera any time after its FDA approval in 1992
  • You developed meningioma

Contact a birth control attorney

If you or a loved one used Depo-Provera and suffered serious side effects like meningioma, contact the medical birth control lawyers at Motley Rice or call us at 800.768.4026.

Timeline for Depo Provera shot lawsuits

10.10.24

October 2024

On October 10, Pfizer Healthcare Ireland released a meningioma warning approved by the Irish Health Products Regulatory Agency. The warning discusses “increased risk of developing meningioma with high doses of medroxyprogesterone acetate … primarily after prolonged use (several years).” It was issued to Irish healthcare professionals.

On July 11, 2024, Pfizer updated its label for Depo-Provera in the United States, but the update did not include mentions of meningioma. No similar warnings have been issued from the U.S. arms of Pfizer to the FDA, U.S. consumer product agencies or U.S. medical professionals.
 

10.01.24

October 2024

On October 1, a woman who had used Depo-Provera for approximately 17 years filed the first Depo-Provera meningioma lawsuit. In 2022, she had been diagnosed with a Grade 1 and a Grade 2 meningioma tumor. Her lawsuit claims that Pfizer knew or should have known that the birth control injections could cause brain tumors. 

05.01.24

May 2024

Pfizer updated Depo-Provera’s Patient Information Leaflet (PIL) in Europe to include information about meningioma under the “Warnings and precautions” section. However, no such info was given to U.S. doctors and consumers.

03.01.24

March 2024

The British Medical Journal (BMJ) released a new study identifying the possibility of an increased risk for meningioma among Depo-Provera users. 

06.01.22

June 2022

The European Journal of Neurology published a study concluding that exposure to medications containing higher doses of progestogen potentially increased the risk of developing meningioma. 

09.01.21

September 2021

Pfizer settled the Depo-Provera bone density loss class action lawsuit, agreeing to pay $1,913,750 to the class members (people harmed) and $262,500 to health insurers. 

05.01.08

May 2008

The Canadian class action against Pfizer for bone mineral density loss was authorized.

View Full Timeline

Study links Depo-Provera to meningioma

A 2024 British Medical Journal (BMJ) study linked use of injectable Depo-Provera to an increased risk of intracranial meningioma.  The researchers looked at those who used medroxyprogesterone acetate injections (Depo-Provera shots) as their primary form of birth control. They concluded that people who used Depo-Provera for a year or more were five times more likely to develop meningioma requiring surgery.

Since an estimated 74 million women around the world use Depo-Provera for birth control, the researchers surmised that the number of meningiomas connected to the contraception could be high. 

Researchers also looked at meningioma risk for other forms of birth control, including other hormonal treatments like progesterone, dydrogesterone and some hormonal intrauterine devices (IUDs). They found no increased risk for these types of birth control.

How likely is Depo-Provera to cause meningioma?

The BMJ study analyzed meningioma cases among people who had taken MPA (Depo-Provera) and those who had not. MPA users who used the medical drug for a year or more were at about 5.6 times greater risk of meningioma than non-users.  

What is meningioma?

Meningiomas are a type of brain tumor that is usually non-malignant. These tumors originate in the tissue (meninges) covering the spinal cord and the brain.  They are commonly found near the top and the outer curve of the brain, but may also form at the base of the skull.  They can spread to other parts of the central nervous system through cerebrospinal fluid.  Although typically characterized as slow-growing and benign tumors, some meningiomas grow rapidly and constrict nearby brain tissue. When this happens, surgery is required. 

There are three grades of meningiomas: 

  • Grade 1: The most common meningiomas, which tend to grow slowly
  • Grade 2: Mid-grade meningiomas, with a higher risk of coming back if removed
  • Grade 3: Malignant, cancerous and fast-growing meningiomas

The symptoms of meningiomas often vary with where the tumor forms. Some potential symptoms include: 

  • Confusion
  • Headaches (more severe in the morning)
  • Inability to hear or smell
  • Seizures
  • Vision issues

People with malignant meningiomas commonly undergo surgery to remove the tumor, followed by radiation or chemotherapy. They sometimes participate in clinical trials to test the potential effectiveness of new treatments and medications.  

How does Depo-Provera work?

Depo-Provera is an injectable form of birth control made by Pfizer.  It works by blocking ovulation, or the release of an egg from a woman's ovary during the reproductive cycle.  If a woman doesn’t ovulate, she can’t become pregnant. As an additional protection against ovulation, Depo-Provera thickens the cervical mucus to stop sperm from reaching the egg.  

Women who use Depo-Provera receive a shot — commonly called the Depo shot or birth control shot — on a routine schedule every three months. A doctor injects the medication into the patient’s arm or buttocks. Depo-Provera contains a progesterone hormone that can protect against pregnancy for up to 14 weeks, although the shots are usually given every 12 weeks. 

Frequently asked questions about lawsuits for Depo-Provera

Is there a class action lawsuit for Depo-Provera?

There is no class action lawsuit for Depo-Provera and meningioma. However, individuals may instead file personal injury lawsuits for their alleged harms. As more people file suits, these cases may be consolidated into a multidistrict litigation setting before a single judge.

A previous class action lawsuit for Depo Provera was filed in Canada. This lawsuit concerned the shot’s connection to bone mineral density loss, and the suit was settled in 2021.

Who is eligible for a lawsuit for Depo Provera?

People diagnosed with meningioma after using Depo-Provera may be eligible to file a Depo-Provera lawsuit. To recover damages, they must demonstrate that their Depo-Provera use caused them to develop meningioma or other serious side effects. 

You can contact a Motley Rice prescription drug and contraceptive attorney to learn more, find out if you qualify for a lawsuit, and discuss the time limit for claims. Don’t delay — if you exceed the statute of limitations for filing a Depo-Provera claim, you won’t be able to file. Statutes of limitations have several variables.

What kind of evidence is needed in a Depo-Provera birth control shot lawsuit?

When you file a lawsuit for Depo-Provera, you and your lawyer will need to demonstrate that: 

  • You used Depo-Provera for birth control according to the manufacturer’s directions and your doctor’s recommendations
  • Your use of Depo-Provera for one year or more (for cases involving meningioma)
  • You suffered severe health effects, including meningioma, related to the use of Depo-Provera
  • You suffered harm and required medical care, including but not limited to surgery, to treat your condition

To document your injuries, you’ll need evidence such as medical records and billings that detail your Depo-Provera use and the associated costs. Attorneys and their staff can help you gather this information and build your case.

What types of damages are available in Depo Provera lawsuits?

When determining the potential value of a lawsuit, lawyers look to damages, including but not limited to emotional and physical harm, as well as actual monetary value associated with injuries and treatment for injuries. When filing lawsuits for those injured by Depo Provera, attorneys will ask that plaintiffs be compensated for their injuries and the damages they suffered. In Depo Provera lawsuits, a meningioma is an “injury.” People (plaintiffs) filing birth control lawsuits may be eligible to seek damages for:

  • Healthcare costs associated with injuries caused by Depo-Provera use
  • Lost wages for time missed from work due to injury-related health issues
  • Pain and suffering 
  • Wrongful death of a loved one (if applicable)

In extreme cases, and in order to punish or force changes in business practices of the defendant, the court or jury may also award additional damages to the injured party. These “punitive damages” can be awarded if a court determines that the defendant’s actions were intentional and/or outrageous under the law. While no award is guaranteed, a lawyer can help explain the damages you might be able to obtain in a Depo-Provera lawsuit.

Our experience litigating for women

The medical attorneys at Motley Rice have represented thousands of women injured by prescription and over-the-counter medications and medical devices, including birth control medications like Depo-Provera and Paragard IUD

If you believe a prescribed birth control product may have injured you or a loved one, the attorneys at Motley Rice have the resources to investigate and help you:

  • Identify the potentially harmful medication 
  • Investigate whether it harmed you
  • Review the manufacturer’s regulatory compliance
  • Examine the manufacturer’s instructions regarding use and warnings about side effects
  • Review other issues that could affect your claim

Learn more about our birth control litigation experience here.

Important Depo-Provera lawsuit updates

Key takeaways about Depo Provera meningioma lawsuit

Why are people filing Depo-Provera lawsuits?

Contact a birth control attorney

Timeline for Depo Provera shot lawsuits

Study links Depo-Provera to meningioma

Frequently asked questions about lawsuits for Depo-Provera

Our experience litigating for women

About the Authors

Sources
  1. BMJ Group. Prolonged use of certain hormone drugs linked to increased brain tumor risk.
  2. Cleveland Clinic. Depo-Provera® (Birth Control Shot).
  3. Healthline. Depo-Provera: Everything to Know About the Birth Control Shot.
  4. Hoisnard L, Laanani M, Passeri T, Duranteau L, Coste J, Zureik M, Froelich S, Weill A. Risk of intracranial meningioma with three potent progestogens: A population‐based case-control study. European Journal of Neurology. 2022 Jun 20;29(9):2801–2809.
  5. Lawyer Monthly. Depo-Provera Lawsuits Allege Link to Brain Cancer.
  6. Mayo Clinic. Depo-Provera (contraceptive injection).
  7. Mayo Clinic. Meningioma.
  8. National Cancer Institute. Meningioma: Diagnosis and Treatment.
  9. Pfizer. Package leaflet: Information for the patient. Depo-Provera 150 mg/ml.
  10. Pfizer Healthcare Ireland. IMPORTANT MEDICINE SAFETY INFORMATION: Medroxyprogesterone acetate: Risk of meningioma and measures to minimise this risk.
  11. Roland N, Neumann A, Hoisnard L, Duranteau L, Froelich S, Zureik M, Weill A. Use of progestogens and the risk of intracranial meningioma: national case-control study. BMJ. 2024;384:e078078. 
Your Legal Options

Start Your Motley Rice Consultation in Simple Steps

Connect with an Attorney1.800.768.4026

1

Submit Information

Call us or fill out our online form with the details of your potential case.

2

Case Review

Our team reviews your information to assess your potential case.

3

Case Consultation

Talk with us about next steps.